Literature DB >> 24952414

Hernia repair in the presence of ascites.

Brett L Ecker1, Edmund K Bartlett2, Rebecca L Hoffman2, Giorgos C Karakousis2, Robert E Roses2, Jon B Morris2, Rachel R Kelz2.   

Abstract

BACKGROUND: The model for end-stage liver disease (MELD) has been validated as a prediction tool for postoperative mortality, but its role in predicting morbidity has not been well studied. We sought to determine the role of MELD, among other factors, in predicting morbidity and mortality in patients with nonmalignant ascites undergoing hernia repair.
METHODS: All patients undergoing hernia repair in the American College of Surgeons National Surgical Quality Improvement database (2009-11) were identified. Those with nonmalignant ascites were compared with patients without ascites. A subset analysis of patients with nonmalignant ascites was performed to evaluate the association between MELD and morbidity and mortality with adjustment for potential confounders. The association of significant factors with the rate of morbidity was displayed using a best-fit polynomial regression.
RESULTS: Of 138,366 hernia repairs, 778 (0.56%) were performed on patients with nonmalignant ascites. Thirty-day morbidity (4% versus 19%) and mortality (0.2% versus 5.3%) were significantly more frequent in patients with ascites (P < 0.001). In univariate analysis of the 636 patients with a calculable MELD, MELD was associated with both morbidity and mortality (P < 0.001 each). In multivariate analysis, MELD remained significantly associated with morbidity (odds ratio [OR] = 1.11). Ventral hernia repair (OR = 2.9), dependent functional status (OR = 2.3), alcohol use (OR = 2.3), emergent operation (OR = 2.0) white blood count (OR = 1.1), and age (OR = 1.02) were also significantly associated with morbidity (P < 0.05).
CONCLUSIONS: Before hernia repair, the MELD score can be used to risk-stratify patients with nonmalignant ascites not only for mortality but also morbidity. Morbidity rates increase rapidly with MELD above 15, but other factors should additionally be accounted for when counseling patients on their perioperative risk.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACS NSQIP; Ascites; Hernia repair; MELD; Morbidity; Mortality

Mesh:

Year:  2014        PMID: 24952414     DOI: 10.1016/j.jss.2014.05.039

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

Review 1.  Umbilical hernia repair in patients with cirrhosis: who, when and how to treat.

Authors:  M Bronswijk; J Jaekers; G Vanella; M Struyve; M Miserez; S van der Merwe
Journal:  Hernia       Date:  2022-05-04       Impact factor: 4.739

2.  Model for End-Stage Liver Disease Underestimates Morbidity and Mortality in Patients with Ascites Undergoing Colectomy.

Authors:  Matthew M Fleming; Fangfang Liu; Yawei Zhang; Kevin Y Pei
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

3.  Abdominal hernias in cirrhotic patients: Surgery or conservative treatment? Results of a prospective cohort study in a high volume center: Cohort study.

Authors:  Rafael Soares Pinheiro; Wellington Andraus; Daniel Reis Waisberg; Lucas Souto Nacif; Liliana Ducatti; Vinicius Rocha-Santos; Márcio A Diniz; Rubens Macedo Arantes; Jan Lerut; Luiz Augusto Carneiro D'Albuquerque
Journal:  Ann Med Surg (Lond)       Date:  2019-11-22

4.  EHS and AHS guidelines for treatment of primary ventral hernias in rare locations or special circumstances.

Authors:  N A Henriksen; R Kaufmann; M P Simons; F Berrevoet; B East; J Fischer; W Hope; D Klassen; R Lorenz; Y Renard; M A Garcia Urena; A Montgomery
Journal:  BJS Open       Date:  2020-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.